The 3rd Oxford drug design conference, Drug Design 2014, will address the latest developments in computational and experimental approaches to fragment- and ligand-based drug design. The conference is aimed at bringing together biologists, chemists and computational scientists from academia and industry to discuss the latest developments and breakthroughs in cutting-edge in silico and experimental drug design approaches. The conference invites abstracts for oral and poster presentation in the following general areas of fragment- and ligand-based drug design…click here for further information